Chiara Ferragni, new partners for her Fenice which is now worth 75 million – Corriere.it

Chiara Ferragni, new partners for her Fenice which is now worth 75 million - Corriere.it

[ad_1]

New partners in the capital of Fenice, the company that carries the Chiara Ferragni brand. Alchimia, an investment vehicle in the venture capital sector founded by Paolo Barletta with the participation of Nicola Bulgari’s Annabel Holding, has signed an agreement for the sale of 26% of Fenice to the club deal promoted by the Avm Gestioni group led by Giovanna Dossena, CEO of Avm. The agreement provides for a progressive sale of shares held by Alchimia up to a maximum of 20 million euro. With an overall evaluation of Fenice set at 75 million euros.The sale transaction should close by the end of the year. To date, 40% of Fenice is held by Alchimia, 32.5% belongs to Sisterhood, 100% controlled by Chiara Ferragn, 13.75% belongs to Pasquale Morgese’s N1 and another 13.75% to Esuriens.

Chiara Ferragni says in a note: I thank Alchimia and Paolo Barletta who have believed in our entrepreneurial adventure over the years. I am proud that Avm has chosen to invest in this brand and that it believes that growth passes through my and my team’s managerial continuity. Dossena, founder and CEO of Avm Gestioni, is also satisfied: Our added value is based precisely on the contribution of our members. They bring with them experience, reputation and vision that will also find great expression in this project.

The objective is therefore the consolidation and growth of the brand with Alchimia, although it will not completely exit from the investment. The journey that began with Chiara Ferragni and her brand – said Barletta, CEO of Alchimia – was an incredible journey that led us to achieve truly sensational and unexpected goals. Alchimia is happy to remain a partner of Fenice, even if to a small extent, to accompany it in future years and continue this journey that began 10 years ago. The operation is the fifth exit for Alchimia since 2018, the year of its foundation, preceded by the IPO on the Nasdaq of Cue Health, by the acquisition of the company Texel by the Dazn group, by the partial sale of the Italian Stardust to the Gedi group and by the sale of the ‘Israeli DiA at Philips.

[ad_2]

Source link